Skip to main content
Premium Trial:

Request an Annual Quote

Waters Integrates Acquity UPLC with ABI/MDS Sciex's Mass Specs

NEW YORK (GenomeWeb News) — Waters has released control software that makes its Acquity ultra-performance liquid chromatographers compatible with Applied Biosystems’ mass spectrometers, Waters said last week. 
 
Waters said the new software is designed to allow scientists to operate its UPLC and ABI’s/MDS Sciex mass specs on a single data system.
 
By combining LC with mass spec, Waters said, “scientists are capable of obtaining much more information from a single analysis than by either technique alone.
 
Last August, Waters reported it had reached an agreement with ABI to develop the control system software, which is now released in connection with an updated Analyst system.
 
Waters also last year partnered with Thermo Fisher Scientific (then Thermo Electron) and with Bruker Biosciences to integrate the Acquity system with those firms’ mass specs.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.